EVC2
Basic information
Region (hg38): 4:5542772-5709548
Links
Phenotypes
GenCC
Source:
- Ellis-van Creveld syndrome (Definitive), mode of inheritance: AR
- acrofacial dysostosis, Weyers type (Definitive), mode of inheritance: AR
- Ellis-van Creveld syndrome (Definitive), mode of inheritance: AR
- acrofacial dysostosis, Weyers type (Strong), mode of inheritance: AD
- Ellis-van Creveld syndrome (Supportive), mode of inheritance: AR
- acrofacial dysostosis, Weyers type (Supportive), mode of inheritance: AD
- Ellis-van Creveld syndrome (Definitive), mode of inheritance: AR
- Ellis-van Creveld syndrome (Strong), mode of inheritance: AR
- acrofacial dysostosis, Weyers type (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Ellis-van Creveld syndrome | AR | Cardiovascular | The condition can involve congenital cardiac anomalies, and awareness may allow early management | Cardiovascular; Craniofacial; Dental; Dermatologic; Musculoskeletal | 12468274; 12571802; 16404586; 17024374; 20184732; 21815252; 22406498; 23026208; 23220543; 23276573 |
ClinVar
This is a list of variants' phenotypes submitted to
- Curry-Hall syndrome;Ellis-van Creveld syndrome (76 variants)
- Ellis-van Creveld syndrome;Curry-Hall syndrome (73 variants)
- Ellis-van Creveld syndrome (17 variants)
- not provided (11 variants)
- not specified (2 variants)
- Short-rib thoracic dysplasia 6 with or without polydactyly (2 variants)
- Jeune thoracic dystrophy (2 variants)
- Inborn genetic diseases (2 variants)
- Curry-Hall syndrome (1 variants)
- Type IV short rib polydactyly syndrome (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EVC2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 658 | 10 | 671 | |||
missense | 379 | 19 | 13 | 411 | ||
nonsense | 66 | 31 | 99 | |||
start loss | 1 | |||||
frameshift | 82 | 49 | 135 | |||
inframe indel | 15 | 15 | ||||
splice donor/acceptor (+/-2bp) | 54 | 61 | ||||
splice region | 12 | 104 | 2 | 118 | ||
non coding | 267 | 98 | 374 | |||
Total | 155 | 134 | 413 | 944 | 121 |
Highest pathogenic variant AF is 0.0000788
Variants in EVC2
This is a list of pathogenic ClinVar variants found in the EVC2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-5562454-T-C | Ellis-van Creveld syndrome | Benign (Jan 13, 2018) | ||
4-5562464-A-T | Ellis-van Creveld syndrome | Benign (Jan 13, 2018) | ||
4-5562641-T-C | Ellis-van Creveld syndrome | Likely benign (Jan 12, 2018) | ||
4-5562707-T-C | Ellis-van Creveld syndrome | Uncertain significance (Jan 13, 2018) | ||
4-5562743-G-A | Ellis-van Creveld syndrome | Uncertain significance (Jan 13, 2018) | ||
4-5562758-G-A | Ellis-van Creveld syndrome | Conflicting classifications of pathogenicity (Jun 10, 2021) | ||
4-5562780-A-G | Ellis-van Creveld syndrome | Uncertain significance (Jan 13, 2018) | ||
4-5562851-G-A | Ellis-van Creveld syndrome;Curry-Hall syndrome | Likely benign (May 09, 2023) | ||
4-5562852-T-C | Inborn genetic diseases | Uncertain significance (Dec 08, 2023) | ||
4-5562856-T-G | Ellis-van Creveld syndrome;Curry-Hall syndrome | Uncertain significance (Jun 27, 2022) | ||
4-5562862-A-C | Ellis-van Creveld syndrome;Curry-Hall syndrome | Uncertain significance (Sep 30, 2022) | ||
4-5562864-G-A | Ellis-van Creveld syndrome | Uncertain significance (Jan 13, 2018) | ||
4-5562866-C-T | Ellis-van Creveld syndrome;Curry-Hall syndrome | Likely benign (Dec 07, 2022) | ||
4-5562881-G-GGCATTCAAAAAGTTCTTCTTTTTC | Meckel-Gruber syndrome • not specified | Uncertain significance (Aug 08, 2024) | ||
4-5562884-A-G | Ellis-van Creveld syndrome;Curry-Hall syndrome | Likely benign (Dec 20, 2023) | ||
4-5562892-A-G | EVC2-related disorder | Uncertain significance (Jul 27, 2024) | ||
4-5562893-G-A | Ellis-van Creveld syndrome;Curry-Hall syndrome | Likely benign (Jan 27, 2024) | ||
4-5562893-GTTC-G | Ellis-van Creveld syndrome | Uncertain significance (May 24, 2023) | ||
4-5562898-T-A | Uncertain significance (Dec 13, 2022) | |||
4-5562905-C-T | Curry-Hall syndrome;Ellis-van Creveld syndrome | Likely benign (Dec 20, 2022) | ||
4-5562907-T-G | Curry-Hall syndrome;Ellis-van Creveld syndrome | Likely benign (Oct 15, 2023) | ||
4-5562908-G-A | Ellis-van Creveld syndrome;Curry-Hall syndrome | Likely benign (May 19, 2022) | ||
4-5562911-A-T | Ellis-van Creveld syndrome;Curry-Hall syndrome | Likely benign (Jan 05, 2024) | ||
4-5562911-AG-A | Ellis-van Creveld syndrome | Uncertain significance (Jan 31, 2018) | ||
4-5562912-G-A | Uncertain significance (Nov 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EVC2 | protein_coding | protein_coding | ENST00000344408 | 22 | 166777 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.02e-34 | 0.000605 | 125535 | 0 | 213 | 125748 | 0.000847 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -2.14 | 847 | 689 | 1.23 | 0.0000416 | 8474 |
Missense in Polyphen | 210 | 184.8 | 1.1363 | 2551 | ||
Synonymous | -3.69 | 369 | 289 | 1.28 | 0.0000187 | 2580 |
Loss of Function | 1.11 | 58 | 67.8 | 0.855 | 0.00000365 | 754 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00139 | 0.00138 |
Ashkenazi Jewish | 0.00159 | 0.00159 |
East Asian | 0.000925 | 0.000925 |
Finnish | 0.00162 | 0.00162 |
European (Non-Finnish) | 0.000743 | 0.000739 |
Middle Eastern | 0.000925 | 0.000925 |
South Asian | 0.000687 | 0.000686 |
Other | 0.000984 | 0.000978 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the EvC complex that positively regulates ciliary Hedgehog (Hh) signaling. Plays a critical role in bone formation and skeletal development. May be involved in early embryonic morphogenesis. {ECO:0000250|UniProtKB:Q8K1G2}.;
- Disease
- DISEASE: Acrofacial dysostosis, Weyers type (WAD) [MIM:193530]: An autosomal dominant condition characterized by dysplastic nails, postaxial polydactyly, dental anomalies, short limbs, short stature and normal intelligence. The phenotype is milder than Ellis-van Creveld syndrome. {ECO:0000269|PubMed:16404586}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Hedgehog signaling pathway - Homo sapiens (human);Hedgehog Signaling Pathway;Signal Transduction;Activation of SMO;Hedgehog ,on, state;Signaling by Hedgehog
(Consensus)
Recessive Scores
- pRec
- 0.134
Intolerance Scores
- loftool
- 0.947
- rvis_EVS
- -0.06
- rvis_percentile_EVS
- 48.79
Haploinsufficiency Scores
- pHI
- 0.117
- hipred
- N
- hipred_score
- 0.146
- ghis
- 0.511
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.635
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Evc2
- Phenotype
- cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; skeleton phenotype; limbs/digits/tail phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype;
Gene ontology
- Biological process
- smoothened signaling pathway
- Cellular component
- nucleus;cytoplasm;cytoskeleton;cilium;integral component of membrane;ciliary membrane;plasma membrane protein complex
- Molecular function